LGALS1 and systemic sclerosis: In SSc, higher concentrations of galectin 1 were associated with the presence of telangiectasias [219], while lower galectin 1 levels were present in patients with pitting scars/DUs, suggesting that this molecule may be a protective factor against the development of SSc-related digital vasculopathy [220].